Form 4: Relay Therapeutics CEO Sanjiv Patel Sells Shares to Cover Tax Obligations

Sanjiv Patel, President and CEO of Relay Therapeutics, sold shares of common stock to cover income tax withholding obligations upon the vesting of restricted stock units.

Summary

• Sanjiv Patel, the President and CEO of Relay Therapeutics, sold shares of the company's common stock on April 23, 2025.
• The sales were executed in two transactions at a price of $2.97 per share.
• 42,769 shares were sold in the first transaction and 18,653 shares were sold in the second transaction.
• These sales were to cover income tax withholding obligations related to the vesting of restricted stock units (RSUs) on April 22, 2025.
• Patel's direct ownership following the reported transactions is 821,667 shares.
• Patel also has indirect ownership through The Patel Family Irrevocable Trust of 2019 (199,548 shares) and The SSP Irrevocable Trust of 2020 (687,355 shares), but disclaims beneficial ownership of these securities.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating routine transactions to cover tax obligations. It doesn't convey strong positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations after vesting of RSUs are a common practice among company executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The stock sale could have a minor, temporary impact on shareholders due to the increased supply of shares in the market.

Key Dates

Keywords

Relay Therapeutics, Sanjiv Patel, RLAY, stock sale, Form 4, insider trading, restricted stock units, RSUs, tax obligations, beneficial ownership